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Identity 
Other names: ER81 




The ETV1 (ETS-translocation variant 1) gene belongs 
to the PEA3-subfamily of erythroblast transformation-
specific (ETS)-family of transcription factors.  
It is located on chromosome 7p21.3, consisting of 13 
exons and spanning approximately 100 kb DNA in 
length (Coutte et al., 1999). 
Transcription 
ETV1 has 7 Refseq transcripts that are generated by 
alternative splicing and alternative transcriptional 
initiation. 
Pseudogene 
No pseudogene reported. 
Protein 
Description 
ETV1 belongs to the PEA3-subfamily of erythroblast 
transformation-specific (ETS)-family of transcription 
factors. There are 7 protein isoforms of ETV1, ranging 
from 374 amino acids to 477 amino acids (~55 kD). 
Expression 
The ETV1 protein is physiologically expressed in the 
central nervous system including the developing 
propioceptive neurons, the motor neurons and the 
dopaminergic neurons (Arber et al., 2000; Flames and 
Hobert, 2009).  
ETV1 is also expressed in the inner core cells of the 
Pacinian corpuscle (Sedy et al., 2006) and in the 
interstitial cells of Cajal (Chen et al., 2007; Chi et al., 
2010).  
Pathologically, the ETV1 protein is aberrantly 
expressed in a subset of melanoma and prostate cancr 
through genomic rearrangements (Jané-Valbuena et al., 
2010; Tomlins et al., 2005), or abnormally highly 
expressed in gastrointestinal stromal tumor (GIST) 
through high endogenous expression and protein 
stabilization by active MAP kinase signaling (Chi et al., 
2010), or partially highly expressed as part of an 
oncogenic fusion protein-EWSR1-ETV1-in Ewing 




ETV1 belongs to the ETS (E-twenty-six) family of 
transcription factors and the PEA3 subfamily 
transcription factors (ETV1, ETV4 and ETV5).  
It specifically recognizes the GGAA core consensus 
DNA motif in the genome and mediates transcriptional 
activation and repression of target genes in cell type 
and cell lineage-specific contexts. 
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The ETV1 gene locus is on the p arm of chromosome 7 (7p21.3), spanning from 13930854 to 14031050 (Feb. 2009 GRCh37/hg19). 
 
Schematics of ETV1 and PEA3-subfamily homolog, ETV4 and ETV5. Transcriptional activation acidic domains are in grey and ETS DNA 
binding domains are in black (adapted from Oh et al., 2012). 
 
ETV1 is critical in the normal development of a 
functional sensory-motor circuitry in the spinal cord 
(Arber et al., 2000), the specification of a group of 
specialized dopaminergic neurons in the central 
nervous system (Flames and Hobert, 2009), the normal 
development of the Pacinian corpuscle (Sedy et al., 
2006), and the normal development and specification of 
the subclasses of interstitial cells of Cajal localized in 
the circular muscle and in the myenteric plexus (Chi et 
al., 2010).  
ETV1 contributes to the pathogenesis of a number of 
cancer types through 1) aberrantly overexpression in 
melanoma and prostate cancer via genomic 
rearrangement (Jané-Valbuena et al., 2010; Tomlins et 
al., 2007; Tomlins et al., 2005), 2) abnormal protein 
stabilization in GIST (Chi et al., 2010), 3) formation of 
the oncogenic fusion protein EWSR1-ETV1 in Ewing 
sarcoma (Jeon et al., 1995). 
Homology 
A member of the ETS-family transcription factor and 
the PEA3 subfamily transcription factors , with most 
sequence homology to ETV5 and ETV4. 
Mutations 
Note 




The prognostic relevance remains to be determined. 
Cytogenetics 
Ewing sarcoma translocation, t(7;22)(p22;q12) that 
fused EWSR1 to the ETV1 gene (Jeon et al., 1995). 
Hybrid/Mutated gene 
EWSR1-ETV1 fusion gene accounts for ~1% of all 
Ewing sarcomas. The majority of Ewing sarcoma 
fusion genes are EWSR1-FLI1 (~85%) and EWSR1-
ERG (~10%). 
Abnormal protein 
EWSR1-ETV1 fusion protein that fuses the first 7 
exons of EWSR1 to the last 3-4 exons of ETV1 (exons 
10 or 11-exon 13). 
 
Common breakpoints of the EWS-ETV1 fusion. DNA-BD: DNA binding domain; Pro: proline-rich activation domain; PTD: pointed domain; 
RGG: arginine-glycine-glycine-rich region; RRM: RNA recognition motif; SYQG: serine-tyrosine-glutamine-glycine-rich region that has a 
high transactivation potential; ZN: zinc finger. Adapted from Janknecht, 2005. 
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Typical breakpoint in prostate cancer fusions. 
 
Oncogenesis 
The EWSR1-ETS (EWSR1-FLI1, EWSR1-ETV1, 
EWSR1-ERG, etc) fusion proteins are thought to be the 
"oncogenic drivers" in Ewing sarcoma. EWSR1-FLI1 
and EWSR1-ERG have been modeled in cell lines 
demonstrating the requirement of the oncogenic fusion 
proteins for Ewing sarcoma cell line growth and 
survival.  




ETV1 fusion seems to confer a poorer prognosis in 
several studies. 
Oncogenesis 
ETV1 is aberrantly overexpressed in prostate cancer 
through genomic rearrangements that result in 
overexpression of a truncated ETV1 or full-length 
ETV1.  
ETV1 is required for the growth of ETV1-positive 
prostate cancer cells and ETV1 overexpression confers 
invasiveness prostate cancer cells (Tomlins et al., 2007; 
Tomlins et al., 2005). 
Melanoma 
Prognosis 
The prognostic relevance remains to be determined. 
Oncogenesis 
ETV1 is amplified in 13% of primary and 18% of 
metastatic melanomas, which results in aberrant 
overexpression. ETV1 is required for growth and 
proliferation of melanoma cells with ETV1 
amplification and it cooperates with oncogenic NRAS 
(G12D) for tumorigenesis in mice (Jané-Valbuena et 
al., 2010). 
Gastrointestinal stromal tumor (GIST) 
Prognosis 
The prognostic relevance remains to be determined. 
Oncogenesis 
ETV1 is naturally highly expressed and is required for 
the development of the interstitial cells of Cajal (ICCs) 
in the gastrointestinal tract that are the precursor cells 
of GIST. It is also highly expressed and required for the 
growth, survival and tumorigenesis of GISTs. It drives 
a core transcriptional program that is conserved in ICC 
and GIST. ETV1 protein level is stabilized by active 
KIT and downstream MAP kinase signaling pathways 
and cooperates with mutant KIT in GIST pathogenesis 
(Chi et al., 2010). 
Breakpoints 
See Figure below. 
 
ETV1 and partners. 
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